Barclays Reiterates Overweight Rating on Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP)

Barclays analysts reiterated a Overweight rating on Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (NASDAQ:BRKRP) on February 13, 2026.

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A operates in the Healthcare sector. The stock currently trades at $291.37 with a market capitalization of $54.4B.